Wezlana

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Wezlana HCPCS:

Q5137

HCPCS Code Descriptor:

Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg

Category:

Q Code

Wezlana NDCs:

Primary Type:

Immunology

Generic/Specialty Status:

Single-Source

Package Type:

Route of Administration:

Subcutaneous

Wezlana CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Wezlana:

Wezlana is a medication manufactured by and aligned to the Q Code: Q5137. Wezlana is administered via the Subcutaneous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

Q5137 Added Date:

July 1, 2024

Q5137 Effective Date:

July 1, 2024

Q5137 Termination Date:

HCPCS Active

Our team did not identify patient assistance information for Wezlana
Our team did not identify patient assistance information for Wezlana
Wezlana prescribing information can be found at the link below:
Our team did not identify a source of side effect information for Wezlana.